Our Firm
Cross-Border Impact Ventures is an impact venture capital firm on a mission to revolutionize venture capital investing in health technology.
Our Investment Universe
We look for audacious companies commercializing globally relevant medical devices, diagnostics, therapeutics and digital health innovations that are prioritizing huge market opportunities in women, children and adolescent health.
We value real world and clinical data.
We focus on 4 key sectors:
- Sexual and reproductive health,
- Maternal, newborn and child health,
- General health, including chronic diseases, and
- Health software infrastructure.
We invest in companies addressing gender health inequalities.
Positive impact and financial returns are not mutually exclusive. We seek opportunities that offer both high impact & high returns.
Our Impact
We believe good health is a right that should not be restricted by gender, age, race, wealth and borders.
We hold ourselves to the highest standard of impact investing and implement recognized impact management processes. We invest with a gender and diversity lens.
Health technologies are more scalable than ever before. The time is now to take a global tailored approach in this sector.
We are enablers
We are specialists in women, children and adolescent health with deep expertise in health technology. We are hands-on investors and support our exceptional management teams with access to new markets, unique forms of capital and health technology expertIse in North America, Europe as well as global markets.
We unlock global impact opportunities
Cutting edge technologies take decades to reach underserved communities. We work with management teams to fast track the process.
Emerging Impact Manager Award
– 2025 –
We work with visionary teams to leapfrog access to world leading affordable technologies for women, children and adolescents.
Media
Cross-Border Impact Ventures Wins Best HealthTech Investment Company 2024 – Canada Award
Wealth & Finance International chooses Cross-Border Impact Ventures as the recipient of the Best HealthTech Investment Company 2024 - Canada Award.
Cross-Border Impact Ventures: Investing In Transformative Health Companies To Meet The Needs Of Women And Children
Pulse 2.0 interviews Managing Partner Annie Theriault about CBIV's mission to be the preferred investor for transformative health technology companies with the potential to meet the needs of women, children, and adolescents across global markets.
Samsung Medison to Acquire French AI Ultrasound Startup Sonio for $92.7M
Samsung Medison plans to acquire Sonio, a Paris-based startup that makes AI-powered software for ultrasound workflows, for about $92.7M USD.
Contact Us
Cross-Border Impact Ventures
661 University Avenue, MaRs Centre, West Tower, Suite 1720, Toronto, ON M5G 1M1
